• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>iShares Nasdaq Biotechnology

iShares Nasdaq Biotechnology

iShares Nasdaq Biotechnology IBB 4 Star

Last Price$287.49Day Change (%)-0.98%
Open Price$290.90Day Change ($)-2.85
Day Range286.60–290.9052-Week Range240.30–303.74

As of Fri 4/21/2017 5:00:00 PM | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. XBiotech's stock plummets after cancer treatment receives disappointing review panel vote

    XBiotech's stock plummets after cancer treatment receives disappointing review panel vote

  2. Why biotech stocks are a healthy bet in sickly broader market

    Why biotech stocks are a healthy bet in sickly broader market

  3. Immune Pharma's stock rockets on heavy volume after license pact

    Immune Pharma's stock rockets on heavy volume after license pact

  4. UPDATE: Ask Arora: How the average investor can keep from getting burned by professionals

    UPDATE: Ask Arora: How the average investor can keep from getting burned by professionals

  5. UPDATE: Ask Arora: How the average investor can keep from getting burned by professionals

    UPDATE: Ask Arora: How the average investor can keep from getting burned by professionals

  6. An ETF for This Lagging Sector

    Biotech companies' returns have diverged from the broader market in recent weeks amid concerns over greater regulation and price discounting.

  7. Where Are the Opportunities in U.S. Health Care?

    As the sector has continued to best the broader market, a look both at the dynamics that would drive further outperformance by the sector and at funds that investors can use to tap those themes.

  8. Why the Short-Term Tumult?

    This article represents opinions of the author and not those of his firm and are subject to change from time to time and do not constitute a recommendation to purchase and sale any security nor to engage in any particular investment strategy. The information contained here has been obtained from ...

  9. Biotech ETFs: Which One Is Best Now?

    The five biotech ETFs have very different portfolios with markedly different performance.

  10. Analytical and Independent

    Jerry Slusiewicz depends on his own analysis and risk-management philosophy to keep client portfolios in order.

12

©2017 Morningstar Advisor. All right reserved.